Shanthi Sivendran, MD, MSCR, MBA

Hematology, Medical Oncology
headshot of Shanthi Sivendran, MD, MSCR, MBA
4.9 with 139 ratings

Sees patients age 18 and up

Shanthi Sivendran, MD, MSCR, MBA

Hematology, Medical Oncology
4.9 with 139 ratings

Sees patients age 18 and up

  • Melanoma Team Leader, Penn Medicine Lancaster General Health
  • Clinical Associate Professor of Medicine (Hematology-Oncology)
  • Dr. Sivendran is a Penn Medicine Lancaster General Health physician.

Meet Dr. Sivendran

I am a hematology/oncology physician who specializes in melanoma and non-melanoma skin cancers.  I serve as the lead of the melanoma/non-melanoma skin cancer disease team. I was instrumental in in the development and integration of a comprehensive skin cancer program here in Lancaster that works closely with our Penn Medicine colleagues in Philadelphia. Our goal is to provide cutting edge skin cancer care closer to home. 

Additionally, I serve as the Senior Vice President of Cancer Care Support for the American Cancer Society.  In this role, I am able to advocate, innovate, and educate on behalf of all cancer patients globally, nationally, and close to home. 

I feel passionately that it is important for patients to have a good understanding of their illness, transparency from their treatment team, and be an active participant in making decisions about their care. My team and I strive to provide this level of care for everyone of our patients and their families. My research interests mirror this passion and mainly involves how to improve illness understanding, communication, and ways to integrate Palliative and supportive care early in the care of patients with cancer. I have started a non-profit organization, Oncologist in my Pocket, that educates other healthcare professionals on palliative oncology.

I remain active in oncology at the national level through the American Society of Clinical Oncology. I serve on several of their committees including the Quality Care Symposium planning committee, the Question Writing educational committee, and the Editorial Board for Cancer. net.

 

Back To Top